Global Erectile Dysfunction Drugs Market Insights and Forecast to 2031

Report ID: 855084 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Erectile Dysfunction Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type
        1.4.2 Sildenafil
        1.4.3 Tadalafil
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application
        1.3.2 Hospital Pharmacies
        1.3.3 Private Clinics
        1.3.4 Retail Pharmacies
        1.3.5 E-Commerce (B2B)
        1.3.6 E-Commerce (B2C)
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2016-2027
    2.2 Global Erectile Dysfunction Drugs Revenue Estimates and Forecasts 2016-2027
    2.3 Global Erectile Dysfunction Drugs Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Erectile Dysfunction Drugs Regions by Sales
        2.4.1 Global Top Erectile Dysfunction Drugs Regions by Sales (2016-2021)
        2.4.2 Global Top Erectile Dysfunction Drugs Regions by Sales (2022-2027)
    2.5 Global Top Erectile Dysfunction Drugs Regions by Revenue
        2.5.1 Global Top Erectile Dysfunction Drugs Regions by Revenue (2016-2021)
        2.5.2 Global Top Erectile Dysfunction Drugs Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Erectile Dysfunction Drugs Sales by Manufacturers
        3.1.1 Global Top Erectile Dysfunction Drugs Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Erectile Dysfunction Drugs Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Drugs Sales in 2020
    3.2 Global Erectile Dysfunction Drugs Revenue by Manufacturers
        3.2.1 Global Top Erectile Dysfunction Drugs Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Erectile Dysfunction Drugs Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Drugs Revenue in 2020
    3.3 Global Erectile Dysfunction Drugs Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Erectile Dysfunction Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Erectile Dysfunction Drugs Sales by Type
        4.1.1 Global Erectile Dysfunction Drugs Historical Sales by Type (2016-2021)
        4.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Type (2022-2027)
        4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    4.2 Global Erectile Dysfunction Drugs Revenue by Type
        4.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Type (2016-2021)
        4.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    4.3 Global Erectile Dysfunction Drugs Price by Type
        4.3.1 Global Erectile Dysfunction Drugs Price by Type (2016-2021)
        4.3.2 Global Erectile Dysfunction Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Erectile Dysfunction Drugs Sales by Application
        5.1.1 Global Erectile Dysfunction Drugs Historical Sales by Application (2016-2021)
        5.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Application (2022-2027)
        5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    5.2 Global Erectile Dysfunction Drugs Revenue by Application
        5.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Application (2016-2021)
        5.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    5.3 Global Erectile Dysfunction Drugs Price by Application
        5.3.1 Global Erectile Dysfunction Drugs Price by Application (2016-2021)
        5.3.2 Global Erectile Dysfunction Drugs Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Erectile Dysfunction Drugs Market Size by Type
        6.1.1 North America Erectile Dysfunction Drugs Sales by Type (2016-2027)
        6.1.2 North America Erectile Dysfunction Drugs Revenue by Type (2016-2027)
    6.2 North America Erectile Dysfunction Drugs Market Size by Application
        6.2.1 North America Erectile Dysfunction Drugs Sales by Application (2016-2027)
        6.2.2 North America Erectile Dysfunction Drugs Revenue by Application (2016-2027)
    6.3 North America Erectile Dysfunction Drugs Market Size by Country
        6.3.1 North America Erectile Dysfunction Drugs Sales by Country (2016-2027)
        6.3.2 North America Erectile Dysfunction Drugs Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Erectile Dysfunction Drugs Market Size by Type
        7.1.1 Europe Erectile Dysfunction Drugs Sales by Type (2017-2027)
        7.1.2 Europe Erectile Dysfunction Drugs Revenue by Type (2017-2027)
    7.2 Europe Erectile Dysfunction Drugs Market Size by Application
        7.2.1 Europe Erectile Dysfunction Drugs Sales by Application (2017-2027)
        7.2.2 Europe Erectile Dysfunction Drugs Revenue by Application (2017-2027)
    7.3 Europe Erectile Dysfunction Drugs Market Size by Country
        7.3.1 Europe Erectile Dysfunction Drugs Sales by Country (2017-2027)
        7.3.2 Europe Erectile Dysfunction Drugs Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Erectile Dysfunction Drugs Market Size by Type
        8.1.1 Asia Pacific Erectile Dysfunction Drugs Sales by Type (2018-2027)
        8.1.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Type (2018-2027)
    8.2 Asia Pacific Erectile Dysfunction Drugs Market Size by Application
        8.2.1 Asia Pacific Erectile Dysfunction Drugs Sales by Application (2018-2027)
        8.2.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Application (2018-2027)
    8.3 Asia Pacific Erectile Dysfunction Drugs Market Size by Region
        8.3.1 Asia Pacific Erectile Dysfunction Drugs Sales by Region (2018-2027)
        8.3.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Erectile Dysfunction Drugs Market Size by Type
        9.1.1 Latin America Erectile Dysfunction Drugs Sales by Type (2019-2027)
        9.1.2 Latin America Erectile Dysfunction Drugs Revenue by Type (2019-2027)
    9.2 Latin America Erectile Dysfunction Drugs Market Size by Application
        9.2.1 Latin America Erectile Dysfunction Drugs Sales by Application (2019-2027)
        9.2.2 Latin America Erectile Dysfunction Drugs Revenue by Application (2019-2027)
    9.3 Latin America Erectile Dysfunction Drugs Market Size by Country
        9.3.1 Latin America Erectile Dysfunction Drugs Sales by Country (2019-2027)
        9.3.2 Latin America Erectile Dysfunction Drugs Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Erectile Dysfunction Drugs Market Size by Type
        6.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Type (2016-2027)
    6.2 Middle East and Africa Erectile Dysfunction Drugs Market Size by Application
        6.2.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Application (2016-2027)
    6.3 Middle East and Africa Erectile Dysfunction Drugs Market Size by Country
        6.3.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Corporation Information
        11.1.2 Eli Lilly Overview
        11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Eli Lilly Erectile Dysfunction Drugs Product Description
        11.1.5 Eli Lilly Related Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Pfizer Erectile Dysfunction Drugs Product Description
        11.2.5 Pfizer Related Developments
    11.3 Bayer
        11.3.1 Bayer Corporation Information
        11.3.2 Bayer Overview
        11.3.3 Bayer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Bayer Erectile Dysfunction Drugs Product Description
        11.3.5 Bayer Related Developments
    11.4 BaiYunShan General Factory
        11.4.1 BaiYunShan General Factory Corporation Information
        11.4.2 BaiYunShan General Factory Overview
        11.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Description
        11.4.5 BaiYunShan General Factory Related Developments
    11.5 S.K. Chemicals
        11.5.1 S.K. Chemicals Corporation Information
        11.5.2 S.K. Chemicals Overview
        11.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Description
        11.5.5 S.K. Chemicals Related Developments
    11.6 Teva Pharma
        11.6.1 Teva Pharma Corporation Information
        11.6.2 Teva Pharma Overview
        11.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Teva Pharma Erectile Dysfunction Drugs Product Description
        11.6.5 Teva Pharma Related Developments
    11.7 Dong-A ST
        11.7.1 Dong-A ST Corporation Information
        11.7.2 Dong-A ST Overview
        11.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Dong-A ST Erectile Dysfunction Drugs Product Description
        11.7.5 Dong-A ST Related Developments
    11.8 Metuchen Pharma
        11.8.1 Metuchen Pharma Corporation Information
        11.8.2 Metuchen Pharma Overview
        11.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Description
        11.8.5 Metuchen Pharma Related Developments
    11.9 Seoul Pharma
        11.9.1 Seoul Pharma Corporation Information
        11.9.2 Seoul Pharma Overview
        11.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Description
        11.9.5 Seoul Pharma Related Developments
    11.10 CSBIO.
        11.10.1 CSBIO. Corporation Information
        11.10.2 CSBIO. Overview
        11.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 CSBIO. Erectile Dysfunction Drugs Product Description
        11.10.5 CSBIO. Related Developments
    11.1 Eli Lilly
        11.1.1 Eli Lilly Corporation Information
        11.1.2 Eli Lilly Overview
        11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Eli Lilly Erectile Dysfunction Drugs Product Description
        11.1.5 Eli Lilly Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Erectile Dysfunction Drugs Value Chain Analysis
    12.2 Erectile Dysfunction Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Erectile Dysfunction Drugs Production Mode & Process
    12.4 Erectile Dysfunction Drugs Sales and Marketing
        12.4.1 Erectile Dysfunction Drugs Sales Channels
        12.4.2 Erectile Dysfunction Drugs Distributors
    12.5 Erectile Dysfunction Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Erectile Dysfunction Drugs Industry Trends
    13.2 Erectile Dysfunction Drugs Market Drivers
    13.3 Erectile Dysfunction Drugs Market Challenges
    13.4 Erectile Dysfunction Drugs Market Restraints

14 Key Findings in The Global Erectile Dysfunction Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Erectile Dysfunction Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Sildenafil
    Table 3. Major Manufacturers of Tadalafil
    Table 4. Major Manufacturers of Others
    Table 5. Global Erectile Dysfunction Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 6. Global Erectile Dysfunction Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Erectile Dysfunction Drugs Sales by Region (2016-2021) & (M Pill)
    Table 8. Global Erectile Dysfunction Drugs Sales Market Share by Region (2016-2021)
    Table 9. Global Erectile Dysfunction Drugs Sales by Region (2016-2021) & (M Pill)
    Table 10. Global Erectile Dysfunction Drugs Sales Market Share by Region (2022-2027)
    Table 11. Global Erectile Dysfunction Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 12. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2016-2021)
    Table 13. Global Erectile Dysfunction Drugs Revenue by Region (2022-2027) & (US$ Million)
    Table 14. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2022-2027)
    Table 15. Global Erectile Dysfunction Drugs Sales by Manufacturers (2016-2021) & (M Pill)
    Table 16. Global Erectile Dysfunction Drugs Sales Share by Manufacturers (2016-2021)
    Table 17. Global Erectile Dysfunction Drugs Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 18. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2016-2021)
    Table 19. Erectile Dysfunction Drugs Price by Manufacturers 2016-2021 (USD/Pill)
    Table 20. Global Erectile Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2020)
    Table 22. Erectile Dysfunction Drugs Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Erectile Dysfunction Drugs Product Offered
    Table 24. Date of Manufacturers Enter into Erectile Dysfunction Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
    Table 27. Global Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
    Table 28. Global Erectile Dysfunction Drugs Sales Share by Type (2016-2021)
    Table 29. Global Erectile Dysfunction Drugs Sales Share by Type (2022-2027)
    Table 30. Global Erectile Dysfunction Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 31. Global Erectile Dysfunction Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 32. Global Erectile Dysfunction Drugs Revenue Share by Type (2016-2021)
    Table 33. Global Erectile Dysfunction Drugs Revenue Share by Type (2022-2027)
    Table 34. Erectile Dysfunction Drugs Price by Type (2016-2021) & (USD/Pill)
    Table 35. Global Erectile Dysfunction Drugs Price Forecast by Type (2022-2027) & (USD/Pill)
    Table 36. Global Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
    Table 37. Global Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
    Table 38. Global Erectile Dysfunction Drugs Sales Share by Application (2016-2021)
    Table 39. Global Erectile Dysfunction Drugs Sales Share by Application (2022-2027)
    Table 40. Global Erectile Dysfunction Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 41. Global Erectile Dysfunction Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 42. Global Erectile Dysfunction Drugs Revenue Share by Application (2016-2021)
    Table 43. Global Erectile Dysfunction Drugs Revenue Share by Application (2022-2027)
    Table 44. Erectile Dysfunction Drugs Price by Application (2016-2021) & (USD/Pill)
    Table 45. Global Erectile Dysfunction Drugs Price Forecast by Application (2022-2027) & (USD/Pill)
    Table 46. North America Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
    Table 47. North America Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
    Table 48. North America Erectile Dysfunction Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 49. North America Erectile Dysfunction Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 50. North America Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
    Table 51. North America Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
    Table 52. North America Erectile Dysfunction Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 53. North America Erectile Dysfunction Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 54. North America Erectile Dysfunction Drugs Sales by Country (2016-2021) & (M Pill)
    Table 55. North America Erectile Dysfunction Drugs Sales by Country (2022-2027) & (M Pill)
    Table 56. North America Erectile Dysfunction Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 57. North America Erectile Dysfunction Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 58. Europe Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
    Table 59. Europe Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
    Table 60. Europe Erectile Dysfunction Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 61. Europe Erectile Dysfunction Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 62. Europe Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
    Table 63. Europe Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
    Table 64. Europe Erectile Dysfunction Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 65. Europe Erectile Dysfunction Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 66. Europe Erectile Dysfunction Drugs Sales by Country (2016-2021) & (M Pill)
    Table 67. Europe Erectile Dysfunction Drugs Sales by Country (2022-2027) & (M Pill)
    Table 68. Europe Erectile Dysfunction Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 69. Europe Erectile Dysfunction Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 70. Asia Pacific Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
    Table 71. Asia Pacific Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
    Table 72. Asia Pacific Erectile Dysfunction Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 73. Asia Pacific Erectile Dysfunction Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 74. Asia Pacific Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
    Table 75. Asia Pacific Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
    Table 76. Asia Pacific Erectile Dysfunction Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 77. Asia Pacific Erectile Dysfunction Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 78. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2016-2021) & (M Pill)
    Table 79. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2022-2027) & (M Pill)
    Table 80. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2016-2021) & (US$ Million)
    Table 81. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2022-2027) & (US$ Million)
    Table 82. Latin America Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
    Table 83. Latin America Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
    Table 84. Latin America Erectile Dysfunction Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 85. Latin America Erectile Dysfunction Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 86. Latin America Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
    Table 87. Latin America Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
    Table 88. Latin America Erectile Dysfunction Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 89. Latin America Erectile Dysfunction Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 90. Latin America Erectile Dysfunction Drugs Sales by Country (2016-2021) & (M Pill)
    Table 91. Latin America Erectile Dysfunction Drugs Sales by Country (2022-2027) & (M Pill)
    Table 92. Latin America Erectile Dysfunction Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 93. Latin America Erectile Dysfunction Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 94. Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
    Table 95. Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
    Table 96. Middle East and Africa Erectile Dysfunction Drugs Revenue by Type (2016-2021) & (US$ Million)
    Table 97. Middle East and Africa Erectile Dysfunction Drugs Revenue by Type (2022-2027) & (US$ Million)
    Table 98. Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
    Table 99. Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
    Table 100. Middle East and Africa Erectile Dysfunction Drugs Revenue by Application (2016-2021) & (US$ Million)
    Table 101. Middle East and Africa Erectile Dysfunction Drugs Revenue by Application (2022-2027) & (US$ Million)
    Table 102. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2016-2021) & (M Pill)
    Table 103. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2022-2027) & (M Pill)
    Table 104. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2016-2021) & (US$ Million)
    Table 105. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2022-2027) & (US$ Million)
    Table 106. Eli Lilly Corporation Information
    Table 107. Eli Lilly Description and Major Businesses
    Table 108. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 109. Eli Lilly Erectile Dysfunction Drugs Product
    Table 110. Eli Lilly Recent Developments
    Table 111. Pfizer Corporation Information
    Table 112. Pfizer Description and Major Businesses
    Table 113. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 114. Pfizer Erectile Dysfunction Drugs Product
    Table 115. Pfizer Recent Developments
    Table 116. Bayer Corporation Information
    Table 117. Bayer Description and Major Businesses
    Table 118. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 119. Bayer Erectile Dysfunction Drugs Product
    Table 120. Bayer Recent Developments
    Table 121. BaiYunShan General Factory Corporation Information
    Table 122. BaiYunShan General Factory Description and Major Businesses
    Table 123. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 124. BaiYunShan General Factory Erectile Dysfunction Drugs Product
    Table 125. BaiYunShan General Factory Recent Developments
    Table 126. S.K. Chemicals Corporation Information
    Table 127. S.K. Chemicals Description and Major Businesses
    Table 128. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 129. S.K. Chemicals Erectile Dysfunction Drugs Product
    Table 130. S.K. Chemicals Recent Developments
    Table 131. Teva Pharma Corporation Information
    Table 132. Teva Pharma Description and Major Businesses
    Table 133. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 134. Teva Pharma Erectile Dysfunction Drugs Product
    Table 135. Teva Pharma Recent Developments
    Table 136. Dong-A ST Corporation Information
    Table 137. Dong-A ST Description and Major Businesses
    Table 138. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 139. Dong-A ST Erectile Dysfunction Drugs Product
    Table 140. Dong-A ST Recent Developments
    Table 141. Metuchen Pharma Corporation Information
    Table 142. Metuchen Pharma Description and Major Businesses
    Table 143. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 144. Metuchen Pharma Erectile Dysfunction Drugs Product
    Table 145. Metuchen Pharma Recent Developments
    Table 146. Seoul Pharma Corporation Information
    Table 147. Seoul Pharma Description and Major Businesses
    Table 148. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 149. Seoul Pharma Erectile Dysfunction Drugs Product
    Table 150. Seoul Pharma Recent Developments
    Table 151. CSBIO. Corporation Information
    Table 152. CSBIO. Description and Major Businesses
    Table 153. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2016-2021)
    Table 154. CSBIO. Erectile Dysfunction Drugs Product
    Table 155. CSBIO. Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Erectile Dysfunction Drugs Distributors List
    Table 159. Erectile Dysfunction Drugs Customers List
    Table 160. Erectile Dysfunction Drugs Market Trends
    Table 161. Erectile Dysfunction Drugs Market Drivers
    Table 162. Erectile Dysfunction Drugs Market Challenges
    Table 163. Erectile Dysfunction Drugs Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Erectile Dysfunction Drugs Product Picture
    Figure 2. Global Erectile Dysfunction Drugs Market Share by Type in 2020 & 2027
    Figure 3. Sildenafil Product Picture
    Figure 4. Tadalafil Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Erectile Dysfunction Drugs Sales Market Share by Application in 2020 & 2027
    Figure 7. Hospital Pharmacies
    Figure 8. Private Clinics
    Figure 9. Retail Pharmacies
    Figure 10. E-Commerce (B2B)
    Figure 11. E-Commerce (B2C)
    Figure 12. Erectile Dysfunction Drugs Report Years Considered
    Figure 13. Global Erectile Dysfunction Drugs Sales 2016-2027 (M Pill)
    Figure 14. Global Erectile Dysfunction Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Erectile Dysfunction Drugs Revenue 2016-2027 (US$ Million)
    Figure 16. Global Erectile Dysfunction Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 17. Global Erectile Dysfunction Drugs Sales Market Share by Region (2016-2021)
    Figure 18. Global Erectile Dysfunction Drugs Sales Market Share by Region (2022-2027)
    Figure 19. North America Erectile Dysfunction Drugs Sales YoY (2016-2027) & (M Pill)
    Figure 20. North America Erectile Dysfunction Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Europe Erectile Dysfunction Drugs Sales YoY (2016-2027) & (M Pill)
    Figure 22. Europe Erectile Dysfunction Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Asia-Pacific Erectile Dysfunction Drugs Sales YoY (2016-2027) & (M Pill)
    Figure 24. Asia-Pacific Erectile Dysfunction Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Latin America Erectile Dysfunction Drugs Sales YoY (2016-2027) & (M Pill)
    Figure 26. Latin America Erectile Dysfunction Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. Middle East & Africa Erectile Dysfunction Drugs Sales YoY (2016-2027) & (M Pill)
    Figure 28. Middle East & Africa Erectile Dysfunction Drugs Revenue YoY (2016-2027) & (US$ Million)
    Figure 29. The Top 10 and Top 5 Players Market Share by Erectile Dysfunction Drugs Sales in 2020
    Figure 30. The Top 10 and Top 5 Players Market Share by Erectile Dysfunction Drugs Revenue in 2020
    Figure 31. Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 32. Global Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    Figure 33. Global Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    Figure 34. Global Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    Figure 35. Global Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    Figure 36. North America Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    Figure 37. North America Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    Figure 38. North America Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    Figure 39. North America Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    Figure 40. North America Erectile Dysfunction Drugs Sales Share by Country (2016-2027)
    Figure 41. North America Erectile Dysfunction Drugs Revenue Share by Country (2016-2027)
    Figure 42. U.S. Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 43. Canada Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 44. Europe Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    Figure 45. Europe Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    Figure 46. Europe Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    Figure 47. Europe Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    Figure 48. Europe Erectile Dysfunction Drugs Sales Share by Country (2016-2027)
    Figure 49. Europe Erectile Dysfunction Drugs Revenue Share by Country (2016-2027)
    Figure 50. Germany Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 51. France Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 52. U.K. Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 53. Italy Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 54. Russia Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 55. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    Figure 56. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    Figure 57. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    Figure 58. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    Figure 59. Asia Pacific Erectile Dysfunction Drugs Sales Share by Region (2016-2027)
    Figure 60. Asia Pacific Erectile Dysfunction Drugs Revenue Share by Region (2016-2027)
    Figure 61. China Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 62. Japan Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 63. South Korea Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 64. India Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 65. Australia Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 66. Taiwan Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 67. Indonesia Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 68. Thailand Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 69. Malaysia Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 70. Philippines Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 71. Latin America Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    Figure 72. Latin America Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    Figure 73. Latin America Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    Figure 74. Latin America Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    Figure 75. Latin America Erectile Dysfunction Drugs Sales Share by Country (2016-2027)
    Figure 76. Latin America Erectile Dysfunction Drugs Revenue Share by Country (2016-2027)
    Figure 77. Mexico Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 78. Brazil Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 79. Argentina Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 80. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Type (2016-2027)
    Figure 81. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2027)
    Figure 82. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Application (2016-2027)
    Figure 83. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2027)
    Figure 84. Middle East and Africa Erectile Dysfunction Drugs Sales Share by Country (2016-2027)
    Figure 85. Middle East and Africa Erectile Dysfunction Drugs Revenue Share by Country (2016-2027)
    Figure 86. Turkey Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 87. Saudi Arabia Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 88. U.A.E Erectile Dysfunction Drugs Revenue (2016-2027) & (US$ Million)
    Figure 89. Erectile Dysfunction Drugs Value Chain
    Figure 90. Erectile Dysfunction Drugs Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Frequently Asked Questions
Erectile Dysfunction Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Erectile Dysfunction Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Erectile Dysfunction Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports